Shoji Kubo

Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Background/Objectives: Intrahepatic cholangiocarcinoma (ICC) is subclassified into small and large duct types. Although these subclassifications may help determine the appropriate treatment strategy, subclassification diagnosis currently depends on postoperative pathological examinations. This study aimed to establish a nomogram to predict ICC subclassifications. Methods: This study included 126 patients with ICC who underwent liver resection. The participants were divided into small and large duct-type ICC groups. A nomogram to predict large duct-type ICC was developed using four diagnostic imaging findings: rim-type enhancement in the early phase, an absence of tumor enhancement in the early phase, the presence of peripheral biliary dilatation due to tumor invasion, the presence of penetrating Glisson’s vessels in the tumor, and two laboratory test results: serum gamma-glutamyl transpeptidase and carbohydrate antigen 19-9 levels. Nomogram performance was also assessed. Moreover, the bootstrap method and calibration plots were used to assess nomogram validity. Results: Seventy and fifty-six patients were pathologically diagnosed with small and large duct-type ICCs, respectively. The area under the curve of the established nomogram was 0.93 and remained 0.91 after Harrell’s bias correction. The sensitivity and specificity of the nomogram developed using the Youden index were higher than those of any of the characteristic imaging findings. Calibration plots demonstrated a strong association between the nomogram and the actual data. Conclusions: We developed a novel preoperative nomogram to predict large duct-type ICC. This nomogram can be clinically useful for predicting the subclassifications of ICCs and may contribute to the establishment of a more appropriate treatment strategy for ICC.

Year:

2025

Background/Purpose This study clarifies the short‐ and long‐term outcomes of liver resection with hepatic vein (HV) reconstruction for liver tumors and identifies the risk factors for poor outcome. Methods We contacted 263 specialized centers in Japan and collected data on this surgical procedure. Patient characteristics, surgical procedures, and outcomes were then analyzed. Results A total of 187 patients were enrolled from 36 institutions. Grade C post‐hepatectomy liver failure (PHLF) and in‐hospital mortality were 3.2% and 1.6%, respectively. The median overall survival (OS) and recurrence‐free survival (RFS) were 49.9 and 9.8 months, respectively. Surgical outcomes, OS and RFS did not differ among three types of liver tumors, colorectal liver metastasis (CRLM) ( n = 127), hepatocellular carcinoma ( n = 27), and intrahepatic cholangiocarcinoma ( n = 27). Patients with CRLM and seven or more courses of preoperative chemotherapy had significantly worse OS. Compared with HV reconstruction for securing liver remnant (LR) function ( n = 148), reconstruction of the only main HV remaining in the LR ( n = 39) had significantly worse short‐term outcomes, but did not result in increased mortality, and showed equivalent OS and RFS. Conclusions Liver resection with HV reconstruction can be achieved safely and contributes to a relatively good long‐term outcome for patients with advanced liver malignancies.

Year:

2024

Year:

2023

Collaborators (5)

Takeaki Ishizawa

Professor

Osaka University

JAPAN
View details

Itaru Endo

-

JAPAN
View details

Yutaro Kato

Fujita Health University

JAPAN
View details

Kazuteru Monden

Fukuyama City Hospital

JAPAN
View details

Masaki Kaibori

Professor

Kansai Medical University

JAPAN
View details